CME Medical Grand Round ~ Evolving Therapeutic Approaches and Shifting Paradigms in the Treatment of

EVENT DETAILS AND REGISTRATION

Date:January 17, 2017

Time: 12:00 PM - 01:00 PM (PT)

Location:Conference Room B

Event Is:

  • Describe current treatment strategies and supporting rationales for the individualized management of transplant-eligible, as well as elderly multiple myeloma patients throughout the lifecycle of the disease
  • Assess the shifting treatment paradigms of multiple myeloma including emerging regimens used in smoldering myeloma, primary therapy, consolidation therapy, maintenance therapy, and relapsed/ refractory disease
  • Evaluate finalized and ongoing clinical trial data utilizing standard of care and/or investigational therapies that have the potential to enhance clinical outcomes in newly diagnosed, relapsed/ refractory, and non-transplant eligible
  • Summarize emerging new classes of therapeutics and potential combinations, primarily in the relapsed/refractory setting

Presenters:Rafael Fonseca, MD Mayo Clinic

ADDITIONAL DETAILS:

Objectives:

  • Describe current treatment strategies and supporting rationales for the individualized management of transplant-eligible, as well as elderly multiple myeloma patients throughout the lifecycle of the disease
  • Assess the shifting treatment paradigms of multiple myeloma including emerging regimens used in smoldering myeloma, primary therapy, consolidation therapy, maintenance therapy, and relapsed/ refractory disease
  • Evaluate finalized and ongoing clinical trial data utilizing standard of care and/or investigational therapies that have the potential to enhance clinical outcomes in newly diagnosed, relapsed/ refractory, and non-transplant eligible
  • Summarize emerging new classes of therapeutics and potential combinations, primarily in the relapsed/refractory setting

Who should attend:

Hematologists, Medical Oncologists, physicians, physicians in training, ocology nurses, pharmacists, physicians', assistants and all other healthcare professional involved and/or interested in the topic.

Sponsor(s):Educational Grand from AbbVie, Celgene Corporation, Pharmacyclics, Inc., Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC., Millenium: The Takeda Oncology Company and Spectrum Pharmaceuticals Inc.

CME credits:1.0 AMA/PRA Category 1  Credit™ The City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. City of Hope designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.TM

R.S.V.P.: First come, first served

Contact:

CME Department